{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:53:02Z","timestamp":1781560382962,"version":"3.54.5"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074284"],"award-info":[{"award-number":["82074284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.phymed.2024.156124","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T18:17:24Z","timestamp":1728152244000},"page":"156124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparative effectiveness of five Chinese patent medicines for non-alcoholic fatty liver disease: A systematic review and Bayesian network meta-analysis"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-3263","authenticated-orcid":false,"given":"Rui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanqi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-6110","authenticated-orcid":false,"given":"Jiarui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.156124_bib0001","first-page":"416","article-title":"The effect of strong liver capsules on glucose and lipid metabolism levels and liver function in patients with non-alcoholic fatty liver disease and","volume":"39","author":"Ba","year":"2024","journal-title":"Obesity Acta Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0002","first-page":"1667","article-title":"Observation of the efficacy of strong liver capsules combined with metformin in the treatment of non-alcoholic fatty liver disease","volume":"25","author":"Bai","year":"2016","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0003","first-page":"64","article-title":"The effectiveness of feili gan ning capsules combined with xuezhi kang in treating non-alcoholic fatty liver disease with concurrent hyperlipidemia","author":"Chen","year":"2007","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0004","first-page":"6545","article-title":"Observation of the therapeutic effectiveness of feili gan ning capsules combined with shell lipid capsules in the treatment of non-alcoholic fatty liver disease","volume":"4","author":"Chen","year":"2017","journal-title":"Electron. J. Clin. Med. Lit."},{"key":"10.1016\/j.phymed.2024.156124_bib0005","first-page":"197","article-title":"Progress in the research on traditional chinese medicine treatment for non-alcoholic fatty liver disease","volume":"21","author":"Chen","year":"2023","journal-title":"Chin. Med. Mod. Distance Educ. China"},{"key":"10.1016\/j.phymed.2024.156124_bib0006","first-page":"1739","article-title":"Clinical observation of Qianggan capsule in treating nonalcoholic fatty liver","author":"Chen","year":"2006","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0007","first-page":"529","article-title":"Treatment of non-alcoholic fatty liver disease in 50 cases with strong liver capsules combined with atorvastatin","volume":"34","author":"Ding","year":"2013","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11901-012-0160-4","article-title":"The AST to ALT ratio: a pattern worth considering","volume":"12","author":"Domanski","year":"2013","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.phymed.2024.156124_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12944-017-0621-4","article-title":"Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.phymed.2024.156124_bib0010","first-page":"490","article-title":"Changes in HOMA-IR and serum TNF-\u03b1 levels in patients with non-alcoholic fatty liver disease treated with dan ning tablets combined with rosuvastatin","volume":"20","author":"Du","year":"2017","journal-title":"J. Pract. Hepatol."},{"key":"10.1016\/j.phymed.2024.156124_bib0011","first-page":"68","article-title":"Clinical efficacy of dan ning tablets in the treatment of non-alcoholic fatty liver disease and its impact on blood lipids, liver function, and liver fibrosis: an analysis. Electron","volume":"6","author":"Fan","year":"2019","journal-title":"J. Clin. Med. Lit."},{"key":"10.1016\/j.phymed.2024.156124_bib0012","first-page":"655","article-title":"Comparative efficacy of huazhi rougan granules and silymarin capsules in the treatment of non-alcoholic fatty liver disease","volume":"12","author":"Fang","year":"2014","journal-title":"Chin. J. Gen. Pract."},{"key":"10.1016\/j.phymed.2024.156124_bib0013","first-page":"640","article-title":"Clinical observation of dan ning tablets combined with simvastatin in the treatment of non-alcoholic fatty liver disease","volume":"11","author":"Feng","year":"2013","journal-title":"Guide China Med"},{"key":"10.1016\/j.phymed.2024.156124_bib0014","first-page":"69","article-title":"Clinical efficacy and observation of fatigue characteristics in the treatment of non-alcoholic fatty liver disease with shell lipid capsules","volume":"46","author":"Fu","year":"2014","journal-title":"New Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ijbiomac.2021.05.066","article-title":"Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation","volume":"183","author":"Gao","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2024.156124_bib0016","first-page":"464","article-title":"Observation of the therapeutic effect of dan ning tablets combined with polyene phosphatidylcholine capsules in the treatment of non-alcoholic fatty liver disease","volume":"32","author":"Gao","year":"2017","journal-title":"Drugs Clin"},{"key":"10.1016\/j.phymed.2024.156124_bib0017","first-page":"339","article-title":"Clinical observation on the treatment of non-alcoholic fatty liver disease with Huazhiluogan Granules","volume":"47","author":"Ge","year":"2015","journal-title":"Inner Mong. Med. J."},{"key":"10.1016\/j.phymed.2024.156124_bib0018","first-page":"3421","article-title":"Effect and mechanism of Qianggan capsule in treating nonalcoholic fatty liver fibrosis","volume":"22","author":"Gu","year":"2011","journal-title":"China Pharm"},{"key":"10.1016\/j.phymed.2024.156124_bib0019","first-page":"3472","article-title":"Observation on the curative effect of Huazurogan Granule combined with Doenkang capsules and elastase enteric-coated tablets in the treatment of nonalcoholic fatty liver","volume":"22","author":"Guo","year":"2013","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0020","first-page":"925","article-title":"Effects of atorvastatin calcium combined with Danning tablets on liver function and lipid levels in patients with nonalcoholic fatty liver disease. Chin","volume":"17","author":"Guo","year":"2018","journal-title":"J. Public Health Eng."},{"key":"10.1016\/j.phymed.2024.156124_bib0021","first-page":"72","article-title":"Curative effect of Danning tablet combined with polyene phosphatidylcholine on nonalcoholic fatty liver. Pract","volume":"18","author":"Guo","year":"2018","journal-title":"Clin. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0022","article-title":"Progress of clinical research on the treatment of nonalcoholic fatty liver with proprietary Chinese medicine","volume":"3","author":"Han","year":"2016","journal-title":"Electron. J. Clin. Med. Lit."},{"key":"10.1016\/j.phymed.2024.156124_bib0023","first-page":"155","article-title":"Comparison of the clinical efficacy between silymarin capsules and huazhi rougan granules in the treatment of non-alcoholic fatty liver disease","volume":"19","author":"Han","year":"2019","journal-title":"World Latest Med. Inf."},{"key":"10.1016\/j.phymed.2024.156124_bib0024","first-page":"126","article-title":"The impact of strong liver capsules on the improvement of clinical symptoms and liver function in patients with non-alcoholic fatty liver disease","volume":"19","author":"Hao","year":"2015","journal-title":"J. Clin. Med. Pract."},{"key":"10.1016\/j.phymed.2024.156124_bib0025","first-page":"901","article-title":"Effects of hawthorn acid on inflammation and oxidative stress in high-fat diet-induced nonalcoholic fatty liver model mice","volume":"30","author":"He","year":"2019","journal-title":"Chinese pharmacy"},{"key":"10.1016\/j.phymed.2024.156124_bib0026","first-page":"1518","article-title":"Curative effect of Qianggan capsule on nonalcoholic fatty liver complicated with hyperlipidemia","volume":"22","author":"He","year":"2016","journal-title":"J. Hainan Med. Univ."},{"key":"10.1016\/j.phymed.2024.156124_bib0027","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2024.156124_bib0028","unstructured":"Huang, M.X., 2010. Effect and mechanism of Qianggan capsule in treating nonalcoholic fatty liver fibrosis."},{"key":"10.1016\/j.phymed.2024.156124_bib0029","first-page":"524","article-title":"Clinical observation of 32 cases of nonalcoholic fatty liver disease treated with Dangfeiliganning capsule","author":"Huang","year":"2007","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0030","first-page":"171","article-title":"Treatment of 38 cases of nonalcoholic steatohepatitis with chitosan capsule combined with polyene phosphatidylcholine","author":"Huo","year":"2008","journal-title":"Chin. J. Integr. Tradit. West. Med. Liver Dis."},{"key":"10.1016\/j.phymed.2024.156124_bib0031","first-page":"484","article-title":"Traditional chinese medicine treatment for non-alcoholic fatty liver disease knocks on the door of international academia","volume":"31","author":"Ji","year":"2021","journal-title":"Chin. J. Integr. Tradit. West. Med. Liver Dis."},{"key":"10.1016\/j.phymed.2024.156124_bib0032","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3736\/jcim20080205","article-title":"Effectiveness of danning tablet in patients with non-alcoholic fatty liver of damp-heat syndrome type: a multicenter randomized controlled trial","volume":"6","author":"Ji","year":"2008","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.phymed.2024.156124_bib0033","first-page":"217","article-title":"Clinical study of shell fat capsule combined with pioglitazone in treatment of nonalcoholic fatty liver","volume":"32","author":"Jiang","year":"2017","journal-title":"Drugs Clin"},{"key":"10.1016\/j.phymed.2024.156124_bib0034","first-page":"93","article-title":"The clinical effectiveness of dan ning tablets in the treatment of non-alcoholic fatty liver disease and its impact on blood lipids, liver function, and liver fibrosis","volume":"30","author":"Li","year":"2018","journal-title":"Med. Pharm. J. Chin. People's Lib. Army"},{"key":"10.1016\/j.phymed.2024.156124_bib0035","first-page":"1947","article-title":"Pathogenesis of nonalcoholic fatty liver and progress of traditional Chinese medicine treatment","volume":"35","author":"Li","year":"2020","journal-title":"Guangming J. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0036","series-title":"Clinical Study on the Treatment of Non-alcoholic Simple Steatosis (Damp-Heat Internal Accumulation Type) With Feili Gan Ning Capsules","author":"Li","year":"2009"},{"key":"10.1016\/j.phymed.2024.156124_bib0037","first-page":"1586","article-title":"Effect of Huazurogan granules on insulin resistance in patients with nonalcoholic steatohepatitis","volume":"39","author":"Li","year":"2017","journal-title":"Chin. Tradit. Patent Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0038","first-page":"39","article-title":"Clinical effect of tononaphthoic acid tablets plus Danning tablets in the treatment of nonalcoholic fatty liver disease and its influence on body mass index, liver function and blood lipid indexes","volume":"8","author":"Li","year":"2023","journal-title":"Clin. Res. Pract."},{"key":"10.1016\/j.phymed.2024.156124_bib0039","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11655-010-0023-1","article-title":"Treatment of non-alcoholic fatty liver disease by Qianggan Capsule","volume":"16","author":"Li","year":"2010","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.phymed.2024.156124_bib0040","first-page":"239","article-title":"Treatment of 30 cases of nonalcoholic steatohepatitis with Atomolan tablets combined with chitosan capsules","volume":"21","author":"Li","year":"2011","journal-title":"Chin. J. Integr. Tradit. West. Med. Liver Dis."},{"key":"10.1016\/j.phymed.2024.156124_bib0041","first-page":"724","article-title":"Application of shell fat capsule in the treatment of non-alcoholic steatohepatitis","author":"Li","year":"2007","journal-title":"Sichuan Med. J."},{"key":"10.1016\/j.phymed.2024.156124_bib0042","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12902-022-01172-7","article-title":"Association between triglyceride-glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus","volume":"22","author":"Li","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.phymed.2024.156124_bib0043","first-page":"2352","article-title":"Effects of Danning tablet combined with fenofibrate on serum type III collagen laminin hyaluronic acid levels in patients with nonalcoholic fatty liver disease","volume":"21","author":"Li","year":"2021","journal-title":"Chin. Rem. Clin."},{"key":"10.1016\/j.phymed.2024.156124_bib0044","first-page":"223","article-title":"Effect of Danning tablet combined with simvastatin on nonalcoholic fatty liver disease","volume":"31","author":"Li","year":"2019","journal-title":"Strait Pharm. J."},{"key":"10.1016\/j.phymed.2024.156124_bib0045","first-page":"38","article-title":"Clinical study of 113 cases of patients with non-alcoholic simple steatosis treated with feili gan ning capsules","volume":"53","author":"Li","year":"2012","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0046","first-page":"804","article-title":"Curative effect of huazhiluogan granule combined with acimus in treating nonalcoholic fatty liver","volume":"23","author":"Liang","year":"2013","journal-title":"Zhejiang J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0047","first-page":"14","article-title":"Clinical observation of the effectiveness of feili gan ning capsules combined with metformin in the treatment of non-alcoholic fatty liver disease Chin","volume":"8","author":"Lin","year":"2015","journal-title":"J. Clin. Ration. Drug Use"},{"key":"10.1016\/j.phymed.2024.156124_bib0048","first-page":"75","article-title":"Clinical study on the treatment of non-alcoholic fatty liver with Huazhiluogan Granules","volume":"17","author":"Lin","year":"2013","journal-title":"J. Clin. Med. Pract."},{"key":"10.1016\/j.phymed.2024.156124_bib0049","first-page":"1257","article-title":"The clinical effect of Qianggan capsule in the treatment of patients with simple obesity and fatty liver and the changes of leptin","volume":"37","author":"Liu","year":"2016","journal-title":"J. Hebei Med. Univ."},{"key":"10.1016\/j.phymed.2024.156124_bib0050","first-page":"600","article-title":"Therapeutic effect of Qianggan capsule on nonalcoholic fatty liver","volume":"23","author":"Liu","year":"2014","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0051","first-page":"1394","article-title":"Clinical study on the treatment of non-alcoholic fatty liver by Huazhiluogan Granule combined with Tiopronin","volume":"34","author":"Luo","year":"2019","journal-title":"Drugs Clin"},{"key":"10.1016\/j.phymed.2024.156124_bib0052","first-page":"77","article-title":"Clinical observation of Danning tablet in treating 76 cases of non-alcoholic fatty liver disease","volume":"30","author":"Ma","year":"2014","journal-title":"Chin. Community Doct."},{"key":"10.1016\/j.phymed.2024.156124_bib0053","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1139\/y98-049","article-title":"The gut as a potential trigger of exercise-induced inflammatory responses","volume":"76","author":"Marshall","year":"1998","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.phymed.2024.156124_bib0054","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","article-title":"Management of dyslipidemia in patients with non-alcoholic fatty liver disease","volume":"24","author":"Martin","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.phymed.2024.156124_bib0055","first-page":"56","article-title":"Clinical study on the treatment of nonalcoholic fatty liver with shell fat capsule","volume":"16","author":"Meng","year":"2009","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0056","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/13880209.2019.1568509","article-title":"Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat","volume":"57","author":"Meng","year":"2019","journal-title":"Pharm Biol"},{"key":"10.1016\/j.phymed.2024.156124_bib0057","first-page":"1998","article-title":"Clinical observation on the treatment of non-alcoholic fatty liver caused by dampness-heat accumulation with Huazhiluogan granules","volume":"35","author":"Nan","year":"2020","journal-title":"Guangming J. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0058","first-page":"763","article-title":"Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota","volume":"11","author":"Nian","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.phymed.2024.156124_bib0059","first-page":"1321","article-title":"Comparison of the predictive value of different obesity indicators and visceral fat index for non-alcoholic fatty liver disease. Chin","volume":"44","author":"Nie","year":"2024","journal-title":"J. Gerontol."},{"key":"10.1016\/j.phymed.2024.156124_bib0060","first-page":"137","article-title":"Observation of the effect of shell lipid capsules in the treatment of non-alcoholic steatohepatitis","volume":"33","author":"Ning","year":"2017","journal-title":"J. Clin. Hepatol."},{"key":"10.1016\/j.phymed.2024.156124_bib0061","first-page":"1951","article-title":"Effect of Qianggan capsule on insulin resistance index and liver fibrosis score in patients with nonalcoholic fatty liver disease","volume":"32","author":"Ou","year":"2016","journal-title":"%J \u4e34\u5e8a\u809d\u80c6\u75c5\u6742\u5fd7"},{"key":"10.1016\/j.phymed.2024.156124_bib0062","first-page":"141","article-title":"The effect of shell fat capsule in the treatment of hyperlipidemia complicated with fatty liver","author":"Peng","year":"2008","journal-title":"Med. J. West China"},{"key":"10.1016\/j.phymed.2024.156124_bib0063","first-page":"110","article-title":"Curative effect of Danning tablet combined with Rosuvastatin on nonalcoholic fatty liver disease","volume":"15","author":"Peng","year":"2015","journal-title":"World Latest Med. Inf."},{"key":"10.1016\/j.phymed.2024.156124_bib0064","first-page":"855","article-title":"Clinical observation of 64 cases of nonalcoholic fatty liver disease treated by Dangliganing. Chin","volume":"21","author":"Qi","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.156124_bib0065","first-page":"438","article-title":"Analysis of the effectiveness of shell lipid capsules combined with glutathione in the treatment of non-alcoholic fatty liver disease","volume":"33","author":"Qin","year":"2021","journal-title":"J. Henan. Med. Coll."},{"key":"10.1016\/j.phymed.2024.156124_bib0066","first-page":"253","article-title":"Treatment of 44 cases of damp-heat accumulation type non-alcoholic fatty liver disease with huazhi rougan granules","volume":"57","author":"Song","year":"2022","journal-title":"Zhejiang J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0067","first-page":"1051","article-title":"Clinical observation of Dangfeiliganning capsule combined with atorvastatin calcium tablets in the treatment of non-alcoholic fatty liver disease","volume":"40","author":"Song","year":"2018","journal-title":"Hebei J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0068","first-page":"65","article-title":"Analysis of the effect of dan ning tablets on blood biochemical indicators and clinical efficacy in patients with non-alcoholic fatty liver disease","volume":"23","author":"Tao","year":"2018","journal-title":"Chin. Hepatol."},{"key":"10.1016\/j.phymed.2024.156124_bib0069","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrgastro.2013.138","article-title":"NAFLD: predictive value of ALT levels for NASH and advanced fibrosis","volume":"10","author":"Torres","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.phymed.2024.156124_bib0070","first-page":"433","article-title":"Clinical analysis of the treatment of patients with non-alcoholic fatty liver disease using silymarin combined with shell lipid capsules","volume":"40","author":"Wang","year":"2019","journal-title":"J. Shandong First Med. Univ. Shandong Acad. Med. Sci."},{"key":"10.1016\/j.phymed.2024.156124_bib0071","first-page":"2201","article-title":"The efficacy of dan ning tablets combined with fenofibrate in the treatment of patients with non-alcoholic fatty liver disease and its impact on liver fibrosis indicators","volume":"31","author":"Wang","year":"2020","journal-title":"Mod. Diagn. Treat."},{"key":"10.1016\/j.phymed.2024.156124_bib0072","first-page":"1669","article-title":"The treatment effect of huazhi rougan granules on damp-heat stasis type non-alcoholic fatty liver disease","volume":"13","author":"Wang","year":"2018","journal-title":"World Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0073","first-page":"1089","article-title":"The effect of strong liver capsules combined with ammonium glycyrrhizinate enteric capsules in the treatment of non-alcoholic fatty liver disease","volume":"28","author":"Wang","year":"2019","journal-title":"Henan Med. J."},{"key":"10.1016\/j.phymed.2024.156124_bib0074","first-page":"88","article-title":"Clinical study on the treatment of non-alcoholic fatty liver disease with dan ning tablets combined with tonilin acid","volume":"34","author":"Wang","year":"2019","journal-title":"Drugs Clin"},{"key":"10.1016\/j.phymed.2024.156124_bib0075","first-page":"38","article-title":"Clinical study of Qianggan capsule in treating nonalcoholic fatty liver complicated with hyperlipidemia","volume":"36","author":"Wang","year":"2015","journal-title":"J. Mudanjiang Med. Univ."},{"key":"10.1016\/j.phymed.2024.156124_bib0076","first-page":"158","article-title":"Observation of curative effect of Danning tablet in treating nonalcoholic fatty liver disease","volume":"12","author":"Wang","year":"2014","journal-title":"Guide China Med"},{"key":"10.1016\/j.phymed.2024.156124_bib0077","first-page":"2007","article-title":"The impact of huazhi rougan granules on intestinal barrier function in patients with non-alcoholic fatty liver disease","volume":"24","author":"Wei","year":"2015","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0078","first-page":"4","article-title":"The effect of feili gan ning capsules in treating non-alcoholic simple steatosis. Pract","volume":"19","author":"Wu","year":"2018","journal-title":"Clin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0079","first-page":"192","article-title":"Clinical study on the treatment of nonalcoholic steatohepatitis with Dangliganine","author":"Wu","year":"2008","journal-title":"J. Sichuan Contin. Educ. Coll. Med. Sci."},{"key":"10.1016\/j.phymed.2024.156124_bib0080","series-title":"To Investigate the Protective Effect of Emodin On Non-Alcoholic Fatty Liver Induced By High Fat Diet Based On FXR Pathway","author":"Wu","year":"2022"},{"key":"10.1016\/j.phymed.2024.156124_bib0081","first-page":"598","article-title":"Effect of Danning tablet combined with polyene phosphatidylcholine on improving liver function in patients with nonalcoholic fatty liver disease","volume":"32","author":"Xiang","year":"2019","journal-title":"Heilongjiang Med. J."},{"key":"10.1016\/j.phymed.2024.156124_bib0082","first-page":"79","article-title":"Observation on the curative effect of Huazhiluogan Granules in treating non-alcoholic fatty liver disease of damp-heat accumulation type. Electron","volume":"5","author":"Xu","year":"2018","journal-title":"J. Clin. Med. Lit."},{"key":"10.1016\/j.phymed.2024.156124_bib0083","first-page":"146","article-title":"Observation of the clinical efficacy of shell lipid capsules in the treatment of non-alcoholic fatty liver disease","volume":"20","author":"Xu","year":"2010","journal-title":"Chin. J. Integr. Tradit. West. Med. Liver Dis."},{"key":"10.1016\/j.phymed.2024.156124_bib0084","first-page":"182","article-title":"Clinical curative effect of shell fat capsule combined with silymarin in the treatment of non-alcoholic fatty liver disease","volume":"25","author":"Xuan","year":"2013","journal-title":"Strait Pharm. J."},{"key":"10.1016\/j.phymed.2024.156124_bib0085","first-page":"157","article-title":"Treatment of damp-heat stagnation type non-alcoholic fatty liver disease with huazhi rougan granules","volume":"21","author":"Yang","year":"2015","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.phymed.2024.156124_bib0086","first-page":"638","article-title":"A randomized controlled study of shell fat capsule in the treatment of nonalcoholic fatty liver","volume":"30","author":"Yang","year":"2014","journal-title":"J. Pract. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0087","first-page":"5","article-title":"Effect and mechanism of Qianggan capsule combined with polyene phosphatidylcholine capsule in the treatment of NAFLD","volume":"49","author":"Yao","year":"2011","journal-title":"China Mod. Doct."},{"key":"10.1016\/j.phymed.2024.156124_bib0088","article-title":"Efficacy analysis of dan ning tablets combined with atorvastatin calcium tablets in the treatment of non-alcoholic fatty liver disease","volume":"18","author":"Yi","year":"2018","journal-title":"World Latest Med. Inf."},{"key":"10.1016\/j.phymed.2024.156124_bib0089","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.156124_bib0090","first-page":"2302","article-title":"Observation on the curative effect of Huazhiluogan Granules in treating non-alcoholic fatty liver disease","volume":"23","author":"Yu","year":"2014","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0091","first-page":"50","article-title":"Treatment of 60 cases of nonalcoholic fatty liver disease with chitosan capsule combined with tiopronin","volume":"21","author":"Yuan","year":"2011","journal-title":"Chin. J. Integr. Tradit. West. Med. Liver Dis."},{"key":"10.1016\/j.phymed.2024.156124_bib0092","first-page":"97","article-title":"Clinical observation of the combined treatment of feili gan ning and lecithin for non-alcoholic steatohepatitis","volume":"15","author":"Zhan","year":"2012","journal-title":"J. Pract. Hepatol."},{"key":"10.1016\/j.phymed.2024.156124_bib0093","first-page":"20","article-title":"Observation of the treatment effect of huazhi rougan granules on damp-heat stagnation type non-alcoholic fatty liver disease and its impact on clinical symptoms of patients. electron","volume":"6","author":"Zhang","year":"2019","journal-title":"J. Clin. Med. Lit."},{"key":"10.1016\/j.phymed.2024.156124_bib0094","first-page":"1","article-title":"Gastrodin inhibits nonalcoholic fatty liver disease by regulating the SREBP1c signaling pathway","author":"Zhang","year":"2024","journal-title":"Chin. J. Exp. Tradit. Med. Formul."},{"key":"10.1016\/j.phymed.2024.156124_bib0095","first-page":"18","article-title":"Exploring the medication patterns of traditional chinese medicine in the treatment of non-alcoholic fatty liver disease based on real-world data","volume":"55","author":"Zhang","year":"2023","journal-title":"New Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0096","first-page":"180","article-title":"Progress of traditional Chinese medicine research on nonalcoholic fatty liver","volume":"20","author":"Zhang","year":"2018","journal-title":"J. Liaoning Univ. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0097","first-page":"1092","article-title":"Clinical effect of Danning tablet combined with simvastatin in the treatment of nonalcoholic fatty liver","volume":"29","author":"Zhang","year":"2020","journal-title":"Henan Med. Res."},{"key":"10.1016\/j.phymed.2024.156124_bib0098","first-page":"124","article-title":"Analysis of the impact of dan ning tablets on liver function and blood lipids in patients with non-alcoholic fatty liver disease and clinical efficacy","volume":"34","author":"Zhang","year":"2018","journal-title":"Chin. Community Doct."},{"key":"10.1016\/j.phymed.2024.156124_bib0099","first-page":"431","article-title":"Observation of the therapeutic effect of silymarin capsules combined with polyene phosphatidylcholine in the treatment of non-alcoholic steatohepatitis","volume":"13","author":"Zheng","year":"2010","journal-title":"J. Pract. Hepatol."},{"key":"10.1016\/j.phymed.2024.156124_bib0100","first-page":"534","article-title":"Analysis of the clinical efficacy of strong liver capsules in the treatment of non-alcoholic fatty liver disease. Chin","volume":"23","author":"Zhou","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phymed.2024.156124_bib0101","first-page":"1190","article-title":"Based on intestinal flora and metabolomics, the mechanism of Huazhiluogan granules in treating non-alcoholic fatty liver was studied","volume":"54","author":"Zhu","year":"2023","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"10.1016\/j.phymed.2024.156124_bib0102","first-page":"36","article-title":"Clinical observation of the treatment of non-alcoholic fatty liver disease with strong liver capsules combined with ganping","author":"Zong","year":"2017","journal-title":"Women's Health Res"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324007815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324007815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:47:52Z","timestamp":1762332472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324007815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":102,"alternative-id":["S0944711324007815"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.156124","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of five Chinese patent medicines for non-alcoholic fatty liver disease: A systematic review and Bayesian network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.156124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156124"}}